bioRxivImmunology
Phagosomal RNA sensing through TLR8 controls susceptibility to tuberculosis
C. Maserumule, C. Passemar, O. Oh, K. Hegyi, K. Brown, A. Weimann, A. Dinan, S. Davila, C. Klapholz, J. Bryant, D. Verma, J. Gadwa, S. Krishnananthasivam, K. Vongtongsalee, E. Kendall, A. Trelles, M. Hibberd, R. Prados-Rosales, K. Andi, S. Kumar, D. Ordway, P. A. MacAry, R. A. Floto
Abstract
Genetic determinants of susceptibility to Mycobacterium tuberculosis (Mtb) are poorly understood but could provide insights into critical pathways involved in infection, informing host-directed therapies and enabling risk stratification at individual and population levels. Through a genome-wide forward genetic screen, we identify the Toll-like Receptor 8 (TLR8), as a key regulator of intracellular killing of Mtb. Pharmacological TLR8 activation enhances killing of phylogenetically diverse clinical isolates of drug-susceptible and multidrug-resistant Mtb by macrophages and during in vivo infection in mice. TLR8 is activated by phagosomal mycobacterial RNA released by extracellular membrane vesicles, and enhances xenophagy-dependent Mtb killing. We find that the TLR8 variant, M1V, common in far eastern populations, enhances intracellular killing of Mtb through preferential signal-dependent trafficking to phagosomes. TLR8 signalling may therefore both regulate susceptibility to tuberculosis and provide novel drug targets. Single sentence summaryRNA released from Mycobacterium tuberculosis in the macrophage phagosome is sensed by the pattern recognition receptor TLR8 controlling host susceptibility to tuberculosis and revealing a druggable pathway for host-directed therapy.
- organism: mouse
- assay: bulk RNA-seq
- research focus: host-pathogen & immune response
- research focus: drug response / drug discovery
- approach: experimental assay
- approach: genetic perturbation / CRISPR
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Interleukin-1 receptor antagonist is a conserved factor for exacerbating tuberculosis susceptibility
O. V. Lee, E. Pathak, … D. I. Kotov·bioRxiv·Oct 27, 2023
- Mycobacterium tuberculosis canonical virulence factors interfere with a late component of the TLR2 response.
A. E. Hinman, C. Jani, … A. K. Barczak·bioRxiv·Oct 6, 2021
- Extracellular Vesicles promote host immunity during an M. tuberculosis infection through RNA Sensing
J. Schorey, Y. Cheng·bioRxiv·Jun 15, 2018
- Interleukin-1 receptor antagonist mediates type I interferon-driven susceptibility to Mycobacterium tuberculosis
Daisy X. Ji, Katherine J. Chen, … Russell E. Vance·bioRxiv·Aug 10, 2018
- Galectin-8 senses phagosomal damage and recruits selective autophagy adapter TAX1BP1 to control Mycobacterium tuberculosis infection in macrophages
S. L. Bell, K. L. Lopez, … R. O. Watson·mBioPeer-reviewed·Aug 31, 2021
- Mycobacterial infection induces a specific human innate immune response
John D Blischak, Ludovic Tailleux, … Yoav Gilad·Scientific ReportsPeer-reviewed·Nov 20, 2015